Remuzat, C.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Innovative Methodology For Pharmaceutical Expenditure Forecast

Rémuzat, C., Toumi, M., Cetinsoy, L., Vataire, A.L., Aballea, S.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 70 KB

english, 2013

2

External Reference Pricing Impact of the Integration of the Amnog Discount In The List Price

Thivolet, M., Cetinsoy, L., Vataire, A.L., Rémuzat, C., Brunet, J., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

3

Difference of perceptions and evaluation of cognitive dysfunction in major depressive disorder patients across psychiatrists internationally

Hammi, E. E., Samp, J., Remuzat, C., Auray, J.-P., Lamure, M., Aballea, S., Kooli, A., Akhras, K., Toumi, M.

Journal:

Therapeutic Advances in Psychopharmacology

Year:

2014

Language:

english

File:

PDF, 1024 KB

english, 2014

4

Is Oncology Drug Financial Toxicity A Specific Us Issue?

Chouaid, C, Rémuzat, C, Caban, A, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 48 KB

english, 2015

5

Value Added Medicines: What Value Repurposed Medicines Might Bring To Society?

Rémuzat, C, Toumi, M

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 61 KB

english, 2016

6

Novel methodology for pharmaceutical expenditure forecast

Vataire, Anne-Lise, Cetinsoy, Laurent, Aballéa, Samuel, Rémuzat, Cécile, Urbinati, Duccio, Kornfeld, Åsa, Mzoughi, Olfa, Toumi, Mondher

Journal:

Journal of Market Access & Health Policy

Year:

2014

Language:

english

File:

PDF, 3.76 MB

english, 2014

7

Key drivers for market penetration of biosimilars in Europe

Rémuzat, Cécile, Dorey, Julie, Cristeau, Olivier, Ionescu, Dan, Radière, Guerric, Toumi, Mondher

Journal:

Journal of Market Access & Health Policy

Year:

2017

Language:

english

File:

PDF, 1.94 MB

english, 2017

8

Value added medicines: what value repurposed medicines might bring to society?

Toumi, Mondher, Rémuzat, Cécile

Journal:

Journal of Market Access & Health Policy

Year:

2017

Language:

english

File:

PDF, 1.34 MB

english, 2017

9

Could Healthcoin Be A Revolution In Healthcare?

Hanna, E, Remuzat, C, Auquier, P, Dussart, C, Toumi, M

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 57 KB

english, 2017

10

Trends in Pragmatic Clinical Trials

Kloc, K, Pisarczyk, K, Lach, S, Rémuzat, C, Toumi, M

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 59 KB

english, 2017

11

PHP67 - CURRENT INITIATIVES & FUTURE OF E-HEALTH FUNDING PATHS

Kloc, K., Lach, S., Dusza, M., Rémuzat, C., Sediri, Y., Palencia, R., Abshagen, D., Toumi, M.

Journal:

Value in Health

Year:

2018

Language:

english

File:

PDF, 708 KB

english, 2018

12

PHP89 Market Access of Drugs in France: Evolution or Revolution?

C. Rémuzat, M. Toumi

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

13

PHP45 Impact of Generics Policy on the Generic Penetration

H. Ammar, C. Rémuzat, M. Toumi

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

14

PHP93 Development of Biosimilar Mark in EU-5 and USA

H. Ammar, C. Rémuzat, M. Houas, M. Toumi

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

15

PHP90 Japanese Pricing Reform in April 2012: Toward Cost Containment

C. Rémuzat, S.M. Karray, M. Houas, M. Toumi

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

16

PHP133 Market Access of Drugs in France and Medico-Economic Assessment

C. Rémuzat, M. Toumi, S. Aballea

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

17

PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic Medication

T. Refaï, A. Millier, M. Toumi, C. Rémuzat, M.C. Angermeyer

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

18

Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey

Angermeyer, Matthias C, Millier, Aurélie, Rémuzat, Cécile, Refaï, Tarek, Toumi, Mondher

Journal:

Year:

2013

Language:

english

File:

PDF, 223 KB

english, 2013

19

Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder

Belgaied, Wael, Samp, Jennifer, Vimont, Alexandre, Rémuzat, Cécile, Aballéa, Samuel, El Hammi, Emna, Kooli, Amna, Toumi, Mondher, Akhras, Kasem

Journal:

European Neuropsychopharmacology

Year:

2014

Language:

english

File:

PDF, 658 KB

english, 2014

20

Dispensation Channels of Anti-TNFs in Inflammatory Bowel Disease

Thivolet, M., Rémuzat, C., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 59 KB

english, 2013

21

Divergence of HTA Decisions Across Countries: Case Analysis of Ivabradine

Thivolet, M., Rémuzat, C., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 80 KB

english, 2013

22

Pharmaceutical Expenditure Forecast Model To Support Health Policy Decision Making

Rémuzat, C., Toumi, M., Vataire, A.L., Cetinsoy, L., Aballea, S.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 71 KB

english, 2013

23

Overview of Coverage with Evidence Development in Sweden

Schroeder, M., Kornfeld, A., Ben Abdallah, I., Rémuzat, C., Toumi, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 56 KB

english, 2013

24

EU Pharmaceutical Expenditure Forecast

Rémuzat, C., Toumi, M., Vataire, A.L., Cetinsoy, L.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 88 KB

english, 2013

25

Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

Rémuzat, C., Vataire, A.L., Cetinsoy, L., Aballea, S., Toumi, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 229 KB

english, 2013

26

Comparative Analysis of Hta Decisions, Price and Reimbursement Level of Orphan Drugs In France and Italy

Korchagina, D., Tavella, F., Rémuzat, C., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 82 KB

english, 2014

27

Boosting Biosimilars Uptake in European Countries

Young, K.E., Rémuzat, C., Urbinati, D., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 82 KB

english, 2014

28

Health Technology Assessment, Price and Reimbursement Review for Orphan Drugs In Italy

Tavella, F., Korchagina, D., Rodrigues, J., Rémuzat, C.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

29

Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

Refaï, T., Millier, A., Rémuzat, C., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 82 KB

english, 2014

30

Health Technology Assessment, Price and Reimbursement Review for Orphan Drugs In France

Korchagina, D., Rémuzat, C., Rodrigues, J., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

31

Orphan Drug Approvals In Europe: Historical Review and Trends

Rodrigues, J., Korchagina, D., Rémuzat, C., Brunet, J., Tavella, F.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

32

An Overview of the Biosimilar Market in the Us

Young, K.E., Rémuzat, C., Urbinati, D., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 61 KB

english, 2014

33

Continuum beliefs and attitudes towards people with mental illness: Results from a national survey in France

Angermeyer, M. C., Millier, A., Remuzat, C., Refai, T., Schomerus, G., Toumi, M.

Journal:

International Journal of Social Psychiatry

Year:

2015

Language:

english

File:

PDF, 636 KB

english, 2015

34

Market Access of Atmps: Overview and Expected Challenges

Hanna, E, Tavella, F, Rémuzat, C, Auquier, P, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 65 KB

english, 2015

35

Biosimilar Substitution Policies: An Overview

Mendoza, C, Ionescu, D, Radière, G, Rémuzat, C, Young, KE, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 50 KB

english, 2015

36

Advanced Therapy Medicinal Products May Dramatically Impact Payers’ Budget

Hanna, E, Rémuzat, C, Auquier, P, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 65 KB

english, 2015

37

Horizontal Vs. Vertical Equity: Market Access of Orphan Drugs In France and Uk

Korchagina, D, Tavella, F, Rémuzat, C, Toumi, M, Falissard, B

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 48 KB

english, 2015

38

Sofosbuvir: The Failure of Pricing Policies In The European Union

Lee, D, Hanna, E, El Hammi, E, Rémuzat, C, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 63 KB

english, 2015

39

Overview Of External Reference Pricing Systems In Europe

Rémuzat, C., Urbinati, D., Roïz, J., Kornfeld, A., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 60 KB

english, 2014

40

A model simulating external reference pricing to support policy decision making in Europe

Vataire, A.L., Cetinsoy, L., Rémuzat, C., Aballea, S., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 59 KB

english, 2014

41

Market Access for Pharmaceuticals In Europe: Future Perspectives

Rémuzat, C, Kornfeld, A, Kornfeld, M, Thivolet, M, Gilabert-Perramon, A, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 46 KB

english, 2015

42

Real Life Impact Of External Reference Pricing In Europe Using A Simulation Model

Rémuzat, C., Vataire, A.L., Kornfeld, A., Aballea, S., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 58 KB

english, 2014

43

French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends

Chouaid, C, Borget, I, Braun, E, Bazil, M, Schaetz, D, Rémuzat, C, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 49 KB

english, 2015

44

Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France

Toumi, M, Rémuzat, C, El Hammi, E, Millier, A, Aballéa, S, Chouaid, C, Falissard, B

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 50 KB

english, 2015

45

Differential Pricing For Pharmaceuticals: Overview Of A Widely Debated Pricing Concept And Key Challenges

Rémuzat, C, Tavella, F, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 50 KB

english, 2015

46

Hta Assessment Comparison Of Orphan Drugs In France And Germany

Rémuzat, C, Mzoughi, O, Rodrigues, J, Korchagina, D, Toumi, M

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 80 KB

english, 2014

47

Potential Societal Value of Biosimilars Adoption: The Example of UK

Mendoza, C, Ionescu, D, Radière, G, Rémuzat, C, Lee, D, Toumi, M

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 49 KB

english, 2015

48

Gap Between Payers And Regulators Management Of Risk Prevents And Delays Patient Access To New Therapy

Zard, J., Kornfeld, A., Rémuzat, C., Toumi, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

49

Nature Of Endpoints In Market Access Agreements

Toumi, M., Zard, J., Rémuzat, C., Ben Abdallah, I., Jaroslawski, S.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

50

Orphan Drug Regulation In The Usa, European Union, Japan and South Korea: A Comparative Analysis

Tomita, N, Lee, H, Korchagina, D, Toumi, M, Rémuzat, C, Falissard, B

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 48 KB

english, 2015